Vivani Medical, Inc. (VANI)
(Delayed Data from NSDQ)
$1.25 USD
0.00 (0.00%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $1.25 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Vivani Medical, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | 0 | 3 |
Cost Of Goods | 0 | 0 | 0 | -1 | 2 |
Gross Profit | 0 | 0 | 0 | 1 | 1 |
Selling & Adminstrative & Depr. & Amort Expenses | 27 | 21 | 9 | 15 | 35 |
Income After Depreciation & Amortization | -27 | -21 | -9 | -15 | -34 |
Non-Operating Income | 1 | 7 | 0 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -26 | -14 | -9 | -15 | -34 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -26 | -14 | -9 | -15 | -34 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -26 | -14 | -9 | -15 | -34 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -27 | -21 | -9 | -15 | -34 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | 0 | 0 |
Income After Depreciation & Amortization | -27 | -21 | -9 | -15 | -34 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 50.85 | 38.24 | 10.94 | NA | 4.90 |
Diluted EPS Before Non-Recurring Items | -0.50 | -0.36 | -0.81 | NA | -5.73 |
Diluted Net EPS (GAAP) | -0.50 | -0.36 | -0.81 | -2.16 | -6.84 |
Fiscal Year end for Vivani Medical, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | NA | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 6.23 | 6.22 | 7.14 | 7.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -6.23 | -6.22 | -7.14 | -7.00 |
Non-Operating Income | NA | 0.19 | 0.19 | 0.36 | 0.48 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -6.04 | -6.03 | -6.78 | -6.53 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -6.04 | -6.03 | -6.78 | -6.53 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -6.04 | -6.03 | -6.78 | -6.53 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 52.20 | 51.03 | 50.84 | 50.80 |
Diluted EPS Before Non-Recurring Items | NA | -0.12 | -0.12 | -0.13 | -0.13 |
Diluted Net EPS (GAAP) | NA | -0.12 | -0.12 | -0.13 | -0.13 |